3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
3
Head & Neck
1
Gastrointestinal
1
Conditions
Stomach Neoplasms
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Anemia, Iron-Deficiency
1
Anemia
1
Adenocarcinoma
1
Interventions
ferric carboxymaltose
5
Epoetin Alfa
2
venetoclax
1
trametinib
1
ruxolitinib
1
regorafenib
1
ponatinib
1
pertuzumab
1
pembrolizumab
1
palbociclib
1
olaparib
1
neratinib
1
lorlatinib
1
lenvatinib
1
iron isomaltoside 1000
1
idelalisib
1
ferrous sulfate
1
ferrous fumarate
1
enzalutamide
1
entrectinib
1
enasidenib
1
durvalumab
1
dehydroftorafur
1
darolutamide
1
dacomitinib
1
dabrafenib
1
copanlisib
1
cobimetinib
1
cabozantinib
1
cabazitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Anemia
×
iron isomaltoside 1000
×
Gastrointestinal
×
Clear all
NCT01927328
2016-10-28
IRON
Nottingham University Hospitals NHS Trust
Phase 4
Unknown
40 enrolled